Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	29.44	11.14	180.77	276.21	8.08	19.69
Short-Term Investments	129.06	109.63	0	0	0	0
Cash & Cash Equivalents	158.5	120.77	180.77	276.21	8.08	19.69
Cash Growth	5.09%	-33.19%	-34.55%	3318.40%	-58.96%	-
Receivables	8	0	0	0	0	0
Other Current Assets	5.88	3.83	5.85	2.47	0.02	0.01
Total Current Assets	172.38	124.6	186.61	278.67	8.1	19.7
Property, Plant & Equipment	24.11	24.81	24.77	1.24	1.94	0.08
Goodwill and Intangibles	23.73	24.31	0	0	0	0
Other Long-Term Assets	0	0	0	0.11	0.11	0.03
Total Long-Term Assets	47.84	49.12	24.77	1.35	2.05	0.11
Total Assets	220.22	173.73	211.38	280.02	10.15	19.81
Accounts Payable	2.29	3.9	7.1	11.95	1.08	0.49
Deferred Revenue	0	7.66	0	0	0	0
Current Debt	1.02	1.23	0	0.17	0.62	0.01
Other Current Liabilities	10.83	12.97	24.54	6.59	2	0.23
Total Current Liabilities	14.14	25.76	31.63	18.71	3.69	0.73
Long-Term Debt	19.76	20.1	18.92	0	0.17	0.01
Other Long-Term Liabilities	2.16	2.16	0	0	0	0
Total Long-Term Liabilities	21.92	22.26	18.92	0	0.17	0.01
Total Liabilities	36.06	48.02	50.56	18.71	3.85	0.74
Total Debt	20.78	21.33	18.92	0.17	0.78	0.02
Debt Growth	2.60%	12.74%	11367.27%	-78.85%	5100.00%	-
Retained Earnings	-289.48	-286.23	-212.44	-91.72	-15.74	-2.92
Comprehensive Income	-0.06	0.06	0	0	0	0
Shareholders' Equity	184.16	125.7	160.82	261.31	-15.65	-2.87
Net Cash / Debt	137.72	99.44	161.84	276.04	7.3	19.68
Net Cash / Debt Growth	5.48%	-38.56%	-41.37%	3681.40%	-62.90%	-
Net Cash Per Share	2.69	2.49	4.90	32.50	7.08	4.61
Working Capital	158.24	98.85	154.98	259.97	4.41	18.97
Book Value Per Share	3.59	3.15	4.87	30.77	-15.18	-0.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).